14 results on '"Scheen, A. J."'
Search Results
2. Sodium–glucose co-transporter type-2 inhibitors for hospitalised patients with COVID-19: safe but not protective
3. Combating the dual burden: therapeutic targeting of common pathways in obesity and type 2 diabetes
4. Add-on value of tirzepatide versus semaglutide
5. GLP-1 receptor agonists: which added value when increasing the dose?
6. Oral semaglutide in Japanese versus non-Japanese patients with type 2 diabetes
7. Pragmatic trials, a step forward to assess cardiovascular efficacy of new glucose-lowering agents
8. SGLT2 inhibitor or GLP-1 receptor agonist in type 2 diabetes?
9. New hope for glucokinase activators in type 2 diabetes?
10. Semaglutide: a promising new glucagon-like peptide-1 receptor agonist
11. Cardiovascular safety of albiglutide and other glucagon-like peptide-1 receptor agonists
12. Once-weekly DPP-4 inhibitors: do they meet an unmet need?
13. Personalising metformin therapy: a clinician's perspective
14. SGLT2 versus DPP4 inhibitors for type 2 diabetes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.